Smart Syringe Market by Product Type (Auto Disable, Active Safety, and Passive Safety), Application (Drug Delivery, Vaccination, and Blood Specimen Collection), Age Group (Pediatric and Adult), and End User, (Hospitals and HMOs, Diabetic Patients, Family Practices, and Psychiatrics): Global Opportunity Analysis and Industry Forecast, 2018 - 2025
- Published Date: 2020-10-18
- Report ID: 3229
- Pages: 301
-
Format:
Smart Syringe Market Overview :
The global smart syringe market was valued at $5,737 million in 2017, and is estimated to garner $13,792 million by 2025, registering a CAGR of 10.3% during the forecast period. Smart syringes are designed with features to offer protection from needle stick injuries, blood-borne diseases such as hepatitis C virus (HCV), hepatitis B virus (HBV), human immunodeficiency virus (HIV), and life-threatening infections. They cater to several applications that include vaccination, drug delivery, and blood specimen collection. Smart syringes are of various types, which include auto disable (AD) syringes, passive safety syringes, and active safety syringes are used depending on the nature of application. Active safety syringes are the most common type of smart syringes used across all healthcare sectors, whereas, auto disable (AD) syringes are the most popular syringes used for vaccination purpose.
The industry is driven by increase in needle stick injuries, high prevalence of blood-borne transmission such as hepatitis B, C, HIV through improper injection practices, growth in adoption of safety syringes, and surge in technological advancements. In addition, the WHO mandate to switch to smart syringes to ensure safe injection practices is a major factor that boosts the growth of the market. However, high cost associated with smart syringes, especially passive safety syringes, low awareness in developing economies, and alternative drug delivery methods are expected to impede the market growth. The global smart syringes market volume is projected to reach 15.8 billion units by 2020 and is anticipated to grow at a CAGR of 8.2 during the forecast period.
The global smart syringe market is segmented based on product type, application, age group, end user, and region. Based on product type, the market is segmented into auto disable (AD) syringes, active safety syringes, and passive safety syringes. Based on application, the market is classified into drug delivery, vaccination, and blood specimen collection. Based on age group, the market is bifurcated into pediatric and adult. Based on end user, the market is categorized into hospitals and HMOs, diabetic patients, family practices, psychiatrics, and others. Based on region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Market Benefits for Smart Syringe Market :
This report entails a detailed quantitative analysis of the current market trends from 2017 to 2025 to identify the prevailing opportunities.
Market estimations are based on a comprehensive analysis of the key developments in the industry.
The global market is comprehensively analyzed with respect to product type, application, age group, end user, and region.
In-depth analysis based on region helps understand the regional market to assist in strategic business planning.
The development strategies adopted by key manufacturers are enlisted to understand the competitive scenario of the market.
Smart Syringe Key Market Segments :
By Product Type
Auto disable syringes
Active safety syringes
Passive safety syringes
By Application
Drug delivery
Vaccination
Blood specimen collection
By Age Group
Pediatric
Adult
By End User
Hospitals and HMOs
Diabetic patients
Family practices (Physicians)
Psychiatrics
Others
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
KEY PLAYERS PROFILED
Welltok, Inc.
Intel Corporation
Nvidia Corporation
Google Inc.
IBM Corporation
Microsoft Corporation
General Vision, Inc.
Enlitic, Inc.
BioXcel Corporation
Berg Health
The other players of the smart syringe market include (companies not profiled in the report):
L.O.M. Medical International
Techcon, Tecan Trading AG
Meissner Filtration Products, Inc.
ARxIUM
Parker Hannifin Corporation
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Market share analysis, 2017
3.4. Percentage analysis of vaccines administered via conventional vs. retractable safety vs nonretractable safety syringes
3.4.1. U.S.
3.4.2. Canada
3.4.3. Mexico
3.4.4. Germany
3.4.5. France
3.4.6. UK
3.4.7. Italy
3.4.8. Spain
3.4.9. Japan
3.4.10. China
3.4.11. India
3.4.12. Brazil
3.5. Porters five forces analysis
3.6. Market dynamics
3.6.1. Drivers
3.6.1.1. Upsurge in incidence of needlestick injuries
3.6.1.2. Increase in awareness of smart syringes
3.6.1.3. Technological advancements
3.6.2. Restraints
3.6.2.1. High cost and unaffordability of safety syringes
3.6.2.2. Alternative modes of drug delivery
3.6.3. Opportunity
3.6.3.1. Rise in need for safety syringes in emerging economies
CHAPTER 4: SMART SYRINGES MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Auto-disable syringes
4.2.1. Key market trends and growth opportunities
4.2.2. Market size and forecast
4.2.3. Market analysis, by country
4.3. Active safety syringes
4.3.1. Key market trends and growth opportunities
4.3.2. Market size and forecast
4.3.3. Market analysis, by country
4.4. Passive safety syringes
4.4.1. Key market trends and growth opportunities
4.4.2. Market size and forecast
4.4.3. Market analysis, by country
CHAPTER 5: SMART SYRINGES MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Drug Delivery
5.2.1. Market size and forecast
5.2.2. Market analysis, by country
5.3. Vaccination
5.3.1. Market size and forecast
5.3.2. Market analysis, by country
5.4. Blood Specimen Collection
5.4.1. Market size and forecast
5.4.2. Market analysis, by country
CHAPTER 6: SMART SYRINGES MARKET, BY AGE GROUP
6.1. Overview
6.1.1. Market size and forecast
6.2. Pediatrics
6.2.1. Market size and forecast
6.2.2. Market analysis, by country
6.3. Adults
6.3.1. Market size and forecast
6.3.2. Market analysis, by country
CHAPTER 7: SMART SYRINGES MARKET, BY END USER
7.1. Overview
7.1.1. Market size and forecast
7.2. Hospitals and HMOs
7.2.1. Market size and forecast
7.2.2. Market analysis, by country
7.3. Diabetic patients
7.3.1. Market size and forecast
7.3.2. Market analysis, by country
7.4. Family practices (Physicians)
7.4.1. Market size and forecast
7.4.2. Market analysis, by country
7.5. Psychiatrics
7.5.1. Market size and forecast
7.5.2. Market analysis, by country
7.6. Others
7.6.1. Market size and forecast
7.6.2. Market analysis, by country
CHAPTER 8: SMART SYRINGES MARKET, BY GEOGRAPHY
8.1. OVERVIEW
8.1.1. Market size and forecast
8.2. North America
8.2.1. Key market trends and opportunities
8.2.2. Market size and forecast, by country
8.2.2.1. U.S. smart syringes market by product
8.2.2.2. U.S. smart syringes market by application
8.2.2.3. U.S. smart syringes market by age group
8.2.2.4. U.S. smart syringes market by end user
8.2.2.5. Canada smart syringes market by product
8.2.2.6. Canada smart syringes market by application
8.2.2.7. Canada smart syringes market by age group
8.2.2.8. Canada smart syringes market by end user
8.2.2.9. Mexico smart syringes market by product
8.2.2.10. Mexico smart syringes market by application
8.2.2.11. Mexico smart syringes market by age group
8.2.2.12. Mexico smart syringes market by end user
8.2.3. North America smart syringes market by product
8.2.4. North America smart syringes market by application
8.2.5. North America smart syringes market by age group
8.2.6. North America smart syringes market by end user
8.3. Europe
8.3.1. Key market trends and opportunities
8.3.2. Market size and forecast, by country
8.3.2.1. Germany smart syringes market by product
8.3.2.2. Germany smart syringes market by application
8.3.2.3. Germany smart syringes market by age group
8.3.2.4. Germany smart syringes market by end user
8.3.2.5. France smart syringes market by product
8.3.2.6. France smart syringes market by application
8.3.2.7. France smart syringes market by age group
8.3.2.8. France smart syringes market by end user
8.3.2.9. UK smart syringes market by product
8.3.2.10. UK smart syringes market by application
8.3.2.11. UK smart syringes market by age group
8.3.2.12. UK smart syringes market by end user
8.3.2.13. Italy smart syringes market by product
8.3.2.14. Italy smart syringes market by application
8.3.2.15. Italy smart syringes market by age group
8.3.2.16. Italy smart syringes market by end user
8.3.2.17. Spain smart syringes market by product
8.3.2.18. Spain smart syringes market by application
8.3.2.19. Spain smart syringes market by age group
8.3.2.20. Spain smart syringes market by end user
8.3.2.21. Rest of Europe smart syringes market by product
8.3.2.22. Rest of Europe smart syringes market by application
8.3.2.23. Rest of Europe smart syringes market by age group
8.3.2.24. Rest of Europe smart syringes market by end user
8.3.3. Europe smart syringes market by product
8.3.4. Europe smart syringes market by application
8.3.5. Europe smart syringes market by age group
8.3.6. Europe smart syringes market by end user
8.4. Asia-Pacific
8.4.1. Key market trends and opportunities
8.4.2. Market size and forecast, by country
8.4.2.1. Japan smart syringes market by product
8.4.2.2. Japan smart syringes market by application
8.4.2.3. Japan smart syringes market by age group
8.4.2.4. Japan smart syringes market by end user
8.4.2.5. China smart syringes market by product
8.4.2.6. China smart syringes market by application
8.4.2.7. China smart syringes market by age group
8.4.2.8. China smart syringes market by end user
8.4.2.9. India smart syringes market by product
8.4.2.10. India smart syringes market by application
8.4.2.11. India smart syringes market by age group
8.4.2.12. India smart syringes market by end user
8.4.2.13. Rest of Asia-Pacific smart syringes market by product
8.4.2.14. Rest of Asia-Pacific smart syringes market by application
8.4.2.15. Rest of Asia-Pacific smart syringes market by age group
8.4.2.16. Rest of Asia-Pacific smart syringes market by end user
8.4.3. Asia-Pacific smart syringes market by product
8.4.4. Asia-Pacific smart syringes market by application
8.4.5. Asia-Pacific smart syringes market by age group
8.4.6. Asia-Pacific smart syringes market by end user
8.5. LAMEA
8.5.1. Key market trends and opportunities
8.5.2. Market size and forecast, by country
8.5.2.1. Brazil smart syringes market by product
8.5.2.2. Brazil smart syringes market by application
8.5.2.3. Brazil smart syringes market by age group
8.5.2.4. Brazil smart syringes market by end user
8.5.2.5. Saudi Arabia smart syringes market by product
8.5.2.6. Saudi Arabia smart syringes market by application
8.5.2.7. Saudi Arabia smart syringes market by age group
8.5.2.8. Saudi Arabia smart syringes market by end user
8.5.2.9. South Africa smart syringes market by product
8.5.2.10. South Africa smart syringes market by application
8.5.2.11. South Africa smart syringes market by age group
8.5.2.12. South Africa smart syringes market by end user
8.5.2.13. Rest of LAMEA smart syringes market by product
8.5.2.14. Rest of LAMEA smart syringes market by application
8.5.2.15. Rest of LAMEA smart syringes market by age group
8.5.2.16. Rest of LAMEA smart syringes market by end user
8.5.3. LAMEA smart syringes market by product
8.5.4. LAMEA smart syringes market by application
8.5.5. LAMEA smart syringes market by age group
8.5.6. LAMEA smart syringes market by end user
CHAPTER 9: COMPANY PROFILES
9.1. BAXTER INTERNATIONAL INC.
9.1.1. Company overview
9.1.2. Company snapshot
9.1.3. Operating business segments
9.1.4. Business performance
9.2. BECTON, DICKINSON AND COMPANY
9.2.1. Company overview
9.2.2. Company snapshot
9.2.3. Operating business segments
9.2.4. Business performance
9.3. B. BRAUN MELSUNGEN AG
9.3.1. Company overview
9.3.2. Company snapshot
9.3.3. Operating business segments
9.3.4. Business performance
9.4. CARDINAL HEALTH, INC.
9.4.1. Company overview
9.4.2. Company snapshot
9.4.3. Operating business segments
9.4.4. Business performance
9.4.5. Key strategic moves and developments
9.5. GERRESHEIMER AG
9.5.1. Company overview
9.5.2. Company snapshot
9.5.3. Operating business segments
9.5.4. Business performance
9.5.5. Key strategic moves and developments
9.6. RETRACTABLE TECHNOLOGIES, INC.
9.6.1. Company overview
9.6.2. Company snapshot
9.6.3. Business performance
9.7. SMITHS GROUP PLC.
9.7.1. Company overview
9.7.2. Company snapshot
9.7.3. Operating business segments
9.7.4. Business performance
9.8. TERUMO CORPORATION
9.8.1. Company overview
9.8.2. Company snapshot
9.8.3. Operating business segments
9.8.4. Business performance
9.8.5. Key strategic moves and developments
9.9. UNILIFE CORPORATION
9.9.1. Company overview
9.9.2. Company snapshot
9.9.3. Operating business segments
9.9.4. Business performance
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
